Method of screening and selecting intraperitoneal medication inf

Details Method of screening and selecting intraperitoneal medication inf Method of screening and selecting intraperitoneal medication inf

1989-01-13

1990-03-27

Sykes, Angela D.

Surgery

Truss

Pad

604 50, 128630, A61B 500

Patent

active

049111680

ABSTRACT:
A method of screening potential recipients of an implantable medication infusion system including an implanted intraperitoneal catheter is disclosed which seeks to select only those candidates who will have a high degree of resistance to catheter blockage due to fibrotic tissue growth. By checking certain physical parameters in candidates for an implantable catheter, and by declining to implant in those candidates who have higher than desirable levels of the parameters, catheter survival in those patients chosen for implant is maximized. The four parameters used are blood triglyceride level, blood cholesterol level, the level of insulin dosage per day, and mean blood glucose (MBG) level, with the first two being the more accurate parameters.

REFERENCES:
patent: 3550581 (1970-12-01), Boyle
patent: 4008717 (1977-02-01), Kowarski
patent: 4266021 (1981-05-01), Nylen
patent: 4731726 (1988-05-01), Allen
patent: 4830013 (1989-05-01), Maxwell

Affiliated with

Also associated with

Rating

Method of screening and selecting intraperitoneal medication inf does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of screening and selecting intraperitoneal medication inf, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of screening and selecting intraperitoneal medication inf will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1644230